Friday’s Insider Moves: Major Buys in Insurance and Biotech, Sells in Energy

This article summarizes the top insider buys and sells for US stocks reported on Friday, March 28, 2025.

Top Insider Buys:

Fidelity National Financial , Inc. (NYSE:FNF) made a significant investment in F&G Annuities & Life, Inc. (NYSE:FG), purchasing 4.5 million shares of common stock at $33.60 each, totaling $151.2 million. The transaction, which closed on March 24, 2025, was part of F&G Annuities’ underwritten public offering. Following the purchase, Fidelity National Financial now holds over 110 million shares of F&G Annuities, further strengthening its position as a major stakeholder in the life insurance company.

Surrozen , Inc. (NASDAQ:SRZN) saw substantial stock purchases by major shareholder The Column Group. On March 26, 2025, The Column Group III, LP, and its affiliates acquired 1,034,482 shares of Surrozen’s common stock at $11.60 per share, amounting to an investment of approximately $11.9 million. This acquisition reflects The Column Group’s continued interest in the biotechnology company, which currently has a market capitalization of $37 million and has experienced an 11.5% decline over the past week.

Staar Surgical Co. (NASDAQ:STAA) reported insider buying from Broadwood Partners, L.P., which acquired 113,384 shares of common stock over three consecutive days from March 26 to March 28, 2025. The purchases, totaling approximately $1.98 million, were executed at prices ranging from $17.40 to $17.50 per share. This strategic move increased Broadwood’s total ownership in Staar Surgical to 12,433,075 shares, demonstrating confidence in the ophthalmic goods company despite its recent 52% stock decline over the past six months.

Globalstar, Inc. (NYSE:NASDAQ:GSAT) director and ten percent owner Monroe James III acquired 209,546 shares of the company’s voting common stock at $22.52 per share, totaling approximately $4.7 million. The purchase was conducted through Thermo XCOM LLC in a private transaction on March 28, 2025. This acquisition increased James’s indirect holdings in Globalstar, with various entities under his control holding substantial shares in the company.

Oncology Institute, Inc. (NASDAQ:TOI) director Richard Barasch made a significant investment by acquiring 1,358,448 shares of common stock at $1.0417 per share, totaling approximately $1.42 million. The transaction was part of a private placement agreement and was executed through RAB Ventures (DFP) LLC, an entity controlled by Barasch. Following this purchase, Barasch’s total direct and indirect ownership stands at 1,775,641 shares of Oncology Institute’s common stock.

Top Insider Sells:

Hess Corp (NYSE:HES) CEO John B. Hess sold 349,000 shares of common stock on March 27 and 28, 2025, at prices ranging from $158.37 to $160.35 per share, totaling approximately $55.6 million. Following these transactions, Hess retains ownership of 2,209,679 shares indirectly through a trust. The sales come as the company, valued at $48.8 billion, trades near its 52-week high with strong financial metrics.

Soleno Therapeutics Inc. (NASDAQ:SLNO) saw significant selling from major shareholder Vivo Opportunity (SO:FTCE11B), LLC, and its affiliate Vivo Opportunity Fund Holdings, L.P. The entities sold a total of 1,833,557 shares over three days, amounting to approximately $124.4 million. The sales occurred at various prices, with the weighted average price per share ranging between $65.8 and $70.6. Following these transactions, Vivo Opportunity Fund Holdings, L.P. now holds approximately 4,458,294 shares of Soleno Therapeutics.

Universal Technical Institute Inc . (NYSE:UTI) reported a notable sale by significant shareholder Coliseum Capital, LLC. The firm sold 1,000,000 shares at $25.35 per share, totaling $25.35 million. Following this sale, Coliseum Capital still retains 5,145,755 shares in the company. The transaction comes as UTI shares have surged 66% over the past year.

AutoZone Inc. (NYSE:AZO) President and CEO Philip B. Daniele sold 2,000 shares of the company’s common stock at an average price of $3,800.01 each, totaling approximately $7.6 million. Daniele also exercised options to acquire 2,000 shares at $744.85 each before executing the sale, as part of a previously established equity incentive plan.

Broadcom Inc. (NASDAQ:AVGO) director Henry Samueli sold 673,046 shares on March 26, 2025, at prices ranging from $178.36 to $187.79 per share, amounting to approximately $120.6 million. Following these transactions, Samueli’s remaining stake in Broadcom stands at 38,662,473 shares. The sales were executed under a prearranged trading plan.

Investors should stay tuned to insider buying and selling activities as they can provide valuable insights into a company’s prospects. While insider transactions alone should not be the sole basis for investment decisions, they can offer clues about management’s confidence in the company’s future performance or potential concerns. It’s important to consider these moves alongside other fundamental and technical analysis when evaluating investment opportunities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.